Literature DB >> 18712386

Outcome of hybrid stem fixation in osteoporotic female patients. A minimum five-year follow-up study.

Francesco Traina1, Enrico Tassinari, Federico Pilla, Marcello De Fine, Federico Biondi, Luca Cristofolini, Aldo Toni.   

Abstract

In osteoporotic patients cemented stems are usually used to achieve a good primary stability. However, when patients are obese or active the long-term survival of cemented prostheses is questioned. In these patients, a partially-cemented stem with a hybrid fixation could be advantageous. A hybrid stem was retrospectively evaluated at a minimum follow-up of 60 months (mean, 75 months) in 58 osteoporotic women: seventeen with a body mass index (BMI) >30 (obese), 41 with a BMI between 25 and 29.9 (overweight), and an UCLA score for activity level >6. At the latest follow up, the Harris hip score improved from 33.5 points preoperatively to 81.6 points, and the WOMAC score improved significantly. Three stems (4.9%) had an asymptomatic subsidence of less than 2.5 mm; no stem was revised. These results support the use of partially-cemented stems in heavy or active osteoporotic women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712386      PMCID: PMC2899187          DOI: 10.1007/s00264-008-0645-5

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  24 in total

1.  Pre-clinical validation of a new partially cemented femoral prosthesis by synergetic use of numerical and experimental methods.

Authors:  M Viceconti; L Cristofolini; M Baleani; A Toni
Journal:  J Biomech       Date:  2001-06       Impact factor: 2.712

2.  Interface biomechanics of the Anca Dual fit hip stem: an in vitro experimental study.

Authors:  L Monti; L Cristofolini; M Viceconti
Journal:  Proc Inst Mech Eng H       Date:  2001       Impact factor: 1.617

3.  Analysis of 16 retrieved proximally cemented femoral stems.

Authors:  Richard E Jones; Bettina M Willie; Harland Hayes; Roy D Bloebaum
Journal:  J Arthroplasty       Date:  2005-01       Impact factor: 4.757

4.  Total hip arthroplasty for primary osteoarthrosis in younger patients in the Finnish arthroplasty register. 4,661 primary replacements followed for 0-22 years.

Authors:  Antti Eskelinen; Ville Remes; Ilkka Helenius; Pekka Pulkkinen; Juha Nevalainen; Pekka Paavolainen
Journal:  Acta Orthop       Date:  2005-02       Impact factor: 3.717

Review 5.  Philosophies of stem designs in cemented total hip replacement.

Authors:  Nico Verdonschot
Journal:  Orthopedics       Date:  2005-08       Impact factor: 1.390

6.  Effect of proximal femoral osteoporosis on cementless hip arthroplasty: a short-term clinical analysis.

Authors:  Xian-feng Lou; Yu-hong Li; Xiang-jin Lin
Journal:  J Zhejiang Univ Sci B       Date:  2007-01       Impact factor: 3.066

7.  Radiological changes around the stem after cementless hip implantation in case of the anatomic medullary locking hip system -- five years results.

Authors:  A Roth; T Winzer; J Babisch; R Fuhrmann; K Sander; R Venbrocks
Journal:  Acta Chir Orthop Traumatol Cech       Date:  2005       Impact factor: 0.531

8.  The cementless PM hip arthroplasty. Four-to-seven-year results.

Authors:  M Dickob; T Martini
Journal:  J Bone Joint Surg Br       Date:  1996-03

9.  Partially cemented AncaDualFit hip stems do not fail in simulated active patients.

Authors:  Luca Cristofolini; Paolo Erani; Amelia Saponara Teutonico; Francesco Traina; Marco Viceconti; Aldo Toni
Journal:  Clin Biomech (Bristol, Avon)       Date:  2006-10-27       Impact factor: 2.063

10.  Assessing activity in joint replacement patients.

Authors:  C A Zahiri; T P Schmalzried; E S Szuszczewicz; H C Amstutz
Journal:  J Arthroplasty       Date:  1998-12       Impact factor: 4.757

View more
  1 in total

1.  Secondary cement injection technique reduces pulmonary embolism in total hip arthroplasty.

Authors:  Florian Schmidutz; Tobias Düll; Ole Voges; Thomas Grupp; Peter Müller; Volkmar Jansson
Journal:  Int Orthop       Date:  2012-04-15       Impact factor: 3.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.